BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 30880022)

  • 1. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.
    Cohen LJ; Cho JH; Gevers D; Chu H
    Gastroenterology; 2019 Jun; 156(8):2174-2189. PubMed ID: 30880022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
    Fritsch J; Abreu MT
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
    Eindor-Abarbanel A; Healey GR; Jacobson K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota and inflammatory bowel disease.
    Goto Y; Kurashima Y; Kiyono H
    Curr Opin Rheumatol; 2015 Jul; 27(4):388-96. PubMed ID: 26002031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
    Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
    Front Immunol; 2018; 9():363. PubMed ID: 29535731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between microbes and the immune response in inflammatory bowel disease.
    Goethel A; Croitoru K; Philpott DJ
    J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome.
    Larmonier CB; Shehab KW; Ghishan FK; Kiela PR
    Biomed Res Int; 2015; 2015():504638. PubMed ID: 26583115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
    Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
    United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immune responses to fungi and the implications for inflammatory bowel disease.
    Limon JJ; Kershaw KM; Underhill DM
    Curr Opin Gastroenterol; 2018 Nov; 34(6):398-403. PubMed ID: 30299290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage interactions with fungi and bacteria in inflammatory bowel disease.
    Leonardi I; Li X; Iliev ID
    Curr Opin Gastroenterol; 2018 Nov; 34(6):392-397. PubMed ID: 30239343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease.
    Yue B; Yu ZL; Lv C; Geng XL; Wang ZT; Dou W
    World J Gastroenterol; 2020 Aug; 26(30):4378-4393. PubMed ID: 32874052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
    Sartor RB; Wu GD
    Gastroenterology; 2017 Feb; 152(2):327-339.e4. PubMed ID: 27769810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.